ArticleCancer cell international2025

Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.

Wenhao Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.